Ignazio Francesco Masala Selected Research

Ignazio Francesco Masala Research Topics

Disease

8	Rheumatoid Arthritis 06/2020 - 11/2016
5	Inflammation (Inflammations) 01/2021 - 11/2016
4	Pain (Aches) 10/2022 - 02/2015
4	Fibromyalgia (Fibrositis) 01/2020 - 03/2016
3	Rheumatic Diseases (Rheumatism) 02/2021 - 01/2018
2	Arthritis (Polyarthritis) 10/2022 - 08/2020
2	Axial Spondyloarthritis 01/2022 - 08/2020
2	COVID-19 02/2021 - 01/2021
2	Infections 06/2020 - 01/2017
1	Mycoses (Diseases, Fungus) 01/2022
1	Psoriatic Arthritis 01/2022
1	Cytokine Release Syndrome 01/2021
1	Atherosclerosis 06/2020
1	Cardiovascular Infections 06/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Fatigue 11/2019
1	Vascular Diseases (Vascular Disease) 11/2019
1	Mood Disorders (Mood Disorder) 11/2019
1	Insulin Resistance 11/2019
1	Osteoarthritis 12/2018
1	Joint Diseases (Joint Disease) 12/2018
1	Arthralgia (Joint Pain) 12/2018
1	Ankylosing Spondylitis 12/2018
1	Musculoskeletal Pain 12/2018
1	Nociceptive Pain 12/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Necrosis 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018

Drug/Important Bio-Agent (IBA)

3	Antirheumatic Agents (DMARD)IBA 10/2022 - 01/2017
3	CytokinesIBA 01/2022 - 01/2017
2	Janus Kinase InhibitorsIBA 10/2022 - 11/2018
2	baricitinibIBA 02/2021 - 01/2021
2	Synthetic DrugsIBA 01/2021 - 11/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2020 - 12/2018
2	Tumor Necrosis Factor InhibitorsIBA 08/2020 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 01/2017
2	SteroidsIBA 01/2018 - 01/2017
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	Immunomodulating AgentsIBA 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	Colchicine FDA LinkGeneric 02/2021
1	Antimalarials (Antimalarial Agents)IBA 02/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2021
1	InterleukinsIBA 01/2021
1	Interleukin-6 InhibitorsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020
1	Methotrexate (Mexate)FDA LinkGeneric 08/2020
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2020
1	AntibodiesIBA 06/2020
1	LipidsIBA 06/2020
1	sarilumabIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Diclofenac (SR 38)FDA LinkGeneric 12/2018
1	Janus KinasesIBA 11/2018
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2018
1	Nucleic AcidsIBA 09/2018
1	AutoantibodiesIBA 09/2018
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2018
1	Abatacept (Orencia)FDA Link 01/2018
1	Pregabalin (Lyrica)FDA Link 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Transfer Factor (Factor, Transfer)IBA 03/2016

Therapy/Procedure

1	Pain Management 10/2022
1	Hyperbaric Oxygenation 01/2020
1	Therapeutics 01/2018
1	Drug Tapering 11/2016
1	Biological Therapy 11/2016
1	Replacement Arthroplasty 02/2015
1	Analgesia 02/2015